202825-46-5 | Propanamide, 2-[[[4-[(3-fluorophenyl)methoxy]phenyl]methyl]amino]-, (2S)-, methanesulfonate (1:1)

Packsize	Purity	Availability	Price	Discounted Price
1g	99%	in stock	$45.00	$31.00
5g	99%	in stock	$142.00	$99.00
25g	99%	in stock	$479.00	$335.00

Description

• Catalog Number: AB04057
• Chemical Name: Propanamide, 2-[[[4-[(3-fluorophenyl)methoxy]phenyl]methyl]amino]-, (2S)-, methanesulfonate (1:1)
• CAS Number: 202825-46-5
• Molecular Formula: C18H23FN2O5S
• Molecular Weight: 398.44902319999994
• MDL Number: MFCD15145475
• SMILES: CS(=O)(=O)O.NC(=O)[C@@H](NCc1ccc(cc1)OCc1cccc(c1)F)C

Computed Properties

• Complexity: 438
• Covalently-Bonded Unit Count: 2
• Defined Atom Stereocenter Count: 1
• Heavy Atom Count: 27
• Hydrogen Bond Acceptor Count: 7
• Hydrogen Bond Donor Count: 3
• Rotatable Bond Count: 7

Literature

• Disposition and metabolism of safinamide, a novel drug for Parkinson's disease, in healthy male volunteers.

  Pharmacology 20130101

• The effect of safinamide, a novel drug for Parkinson's disease, on pressor response to oral tyramine: a randomized, double-blind, clinical trial.

  Clinical pharmacology and therapeutics 20121001

• A randomized, double-blind, placebo-controlled trial of safinamide as add-on therapy in early Parkinson's disease patients.

  Movement disorders : official journal of the Movement Disorder Society 20120101

• Pressor response to oral tyramine during co-administration with safinamide in healthy volunteers.

  Naunyn-Schmiedeberg's archives of pharmacology 20111201

• A validated chiral liquid chromatographic method for the enantiomeric separation of safinamide mesilate, a new anti-Parkinson drug.

  Journal of pharmaceutical and biomedical analysis 20110428

• Safinamide in the treatment of Parkinson's disease.

  Expert opinion on pharmacotherapy 20100901

• Two polymorphs of safinamide, a selective and reversible inhibitor of monoamine oxidase B.

  Acta crystallographica. Section C, Crystal structure communications 20100601

• Merging the structural motifs of functionalized amino acids and alpha-aminoamides: compounds with significant anticonvulsant activities.

  Journal of medicinal chemistry 20100513

• An expert opinion on safinamide in Parkinson's disease.

  Expert opinion on investigational drugs 20080701

• Monoamine oxidase-B inhibition in the treatment of Parkinson's disease.

  Pharmacotherapy 20071201

• Structures of human monoamine oxidase B complexes with selective noncovalent inhibitors: safinamide and coumarin analogs.

  Journal of medicinal chemistry 20071115

• Solid-phase synthesis and insights into structure-activity relationships of safinamide analogues as potent and selective inhibitors of type B monoamine oxidase.

  Journal of medicinal chemistry 20071004

• Safinamide for the treatment of Parkinson's disease, epilepsy and restless legs syndrome.

  Current opinion in investigational drugs (London, England : 2000) 20070701

• Safinamide.

  Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics 20070101

• Safinamide: from molecular targets to a new anti-Parkinson drug.

  Neurology 20061010

• Symptom relief in Parkinson disease by safinamide: Biochemical and clinical evidence of efficacy beyond MAO-B inhibition.

  Neurology 20061010

• Bioassay of safinamide in biological fluids of humans and various animal species.

  Arzneimittel-Forschung 20060101

• Improvement of motor function in early Parkinson disease by safinamide.

  Neurology 20040824

• Pharmacokinetics and pharmacodynamics of safinamide, a neuroprotectant with antiparkinsonian and anticonvulsant activity.

  Pharmacological research 20040701

• Safinamide: FCE 26743, NW 1015, PNU 151774, PNU 151774E.

  Drugs in R&D 20040101

• Pressor response to intravenous tyramine in healthy subjects after safinamide, a novel neuroprotectant with selective, reversible monoamine oxidase B inhibition.

  Clinical neuropharmacology 20030101

• Safinamide (Newron Pharmaceuticals).

  Current opinion in investigational drugs (London, England : 2000) 20010601